These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 38730728)
1. The Current Role of Radiation in the Management of Cholangiocarcinoma-A Narrative Review. Verma S; Grindrod N; Breadner D; Lock M Cancers (Basel); 2024 May; 16(9):. PubMed ID: 38730728 [TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review. Rizzo A; Brandi G Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174 [TBL] [Abstract][Full Text] [Related]
3. Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs. Spolverato G; Glavas D; Hewitt DB; Brown ZJ; Capelli G; Bergamo F; Rizzato MD; Pawlik TM Expert Opin Pharmacother; 2022 Mar; 23(4):473-481. PubMed ID: 34964678 [TBL] [Abstract][Full Text] [Related]
4. Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Elvevi A; Laffusa A; Scaravaglio M; Rossi RE; Longarini R; Stagno AM; Cristoferi L; Ciaccio A; Cortinovis DL; Invernizzi P; Massironi S Ann Hepatol; 2022; 27(5):100737. PubMed ID: 35809836 [TBL] [Abstract][Full Text] [Related]
5. Future directions in the treatment of cholangiocarcinoma. Zhu AX Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434 [TBL] [Abstract][Full Text] [Related]
6. Advances in targeted therapy of cholangiocarcinoma. Li Y; Yu J; Zhang Y; Peng C; Song Y; Liu S Ann Med; 2024 Dec; 56(1):2310196. PubMed ID: 38359439 [TBL] [Abstract][Full Text] [Related]
10. Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma. Lu X; Green BL; Xie C; Liu C; Chen X JHEP Rep; 2023 Jul; 5(7):100723. PubMed ID: 37229173 [TBL] [Abstract][Full Text] [Related]
11. A narrative review of intrahepatic cholangiocarcinoma: a surgical curative option. Melandro F; Nasto RA; Ginesini M; Balzano E; Bindi ML; Ghinolfi D; Lai Q Chin Clin Oncol; 2023 Apr; 12(2):13. PubMed ID: 37038053 [TBL] [Abstract][Full Text] [Related]
12. A review of the clinical diagnosis and therapy of cholangiocarcinoma. Yao D; Kunam VK; Li X J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497 [TBL] [Abstract][Full Text] [Related]
14. Updates in the use of targeted therapies for the treatment of cholangiocarcinoma. Lodl E; Ramnaraign B; Sahin I; Wheeler S J Oncol Pharm Pract; 2023 Jul; 29(5):1206-1217. PubMed ID: 37097888 [TBL] [Abstract][Full Text] [Related]
15. Narrative review: current management and novel targeted therapies in intrahepatic cholangiocarcinoma. Bath NM; Pawlik TM Chin Clin Oncol; 2023 Feb; 12(1):5. PubMed ID: 36922354 [TBL] [Abstract][Full Text] [Related]
16. [Current Studies and Evidence in Cholangiocarcinoma]. Zimpel C; Mitzlaff K; Jasper NA; Marquardt JU Zentralbl Chir; 2022 Aug; 147(4):389-397. PubMed ID: 35863357 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers. Chen R; Zheng D; Li Q; Xu S; Ye C; Jiang Q; Yan F; Jia Y; Zhang X; Ruan J Cancer Lett; 2022 Oct; 546():215853. PubMed ID: 35921970 [TBL] [Abstract][Full Text] [Related]
18. Systemic treatment of advanced or recurrent biliary tract cancer. Zhang W; Zhou H; Wang Y; Zhang Z; Cao G; Song T; Zhang T; Li Q Biosci Trends; 2020 Nov; 14(5):328-341. PubMed ID: 32830166 [TBL] [Abstract][Full Text] [Related]
19. The new insight of treatment in Cholangiocarcinoma. Li Y; Song Y; Liu S J Cancer; 2022; 13(2):450-464. PubMed ID: 35069894 [TBL] [Abstract][Full Text] [Related]